TNSN92115A1 - Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisation - Google Patents
Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisationInfo
- Publication number
- TNSN92115A1 TNSN92115A1 TNTNSN92115A TNSN92115A TNSN92115A1 TN SN92115 A1 TNSN92115 A1 TN SN92115A1 TN TNSN92115 A TNTNSN92115 A TN TNSN92115A TN SN92115 A TNSN92115 A TN SN92115A TN SN92115 A1 TNSN92115 A1 TN SN92115A1
- Authority
- TN
- Tunisia
- Prior art keywords
- preparation
- benzimidazoles
- substitutes
- compounds
- intermediates
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 150000001556 benzimidazoles Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9103776A SE9103776D0 (sv) | 1991-12-19 | 1991-12-19 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN92115A1 true TNSN92115A1 (fr) | 1993-06-08 |
Family
ID=20384667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN92115A TNSN92115A1 (fr) | 1991-12-19 | 1992-12-18 | Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisation |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0628049A1 (no) |
JP (1) | JPH07502503A (no) |
KR (1) | KR940703840A (no) |
CN (1) | CN1031827C (no) |
AP (1) | AP397A (no) |
AU (1) | AU665043B2 (no) |
CA (1) | CA2124689A1 (no) |
CZ (1) | CZ146794A3 (no) |
FI (1) | FI942912A0 (no) |
HR (1) | HRP921400A2 (no) |
HU (1) | HUT68270A (no) |
IL (1) | IL104025A0 (no) |
IS (2) | IS4079A (no) |
MA (1) | MA22746A1 (no) |
MX (1) | MX9207269A (no) |
NO (1) | NO942230D0 (no) |
NZ (1) | NZ246220A (no) |
SE (1) | SE9103776D0 (no) |
SI (1) | SI9200402A (no) |
SK (1) | SK73594A3 (no) |
TN (1) | TNSN92115A1 (no) |
TW (1) | TW224100B (no) |
WO (1) | WO1993012124A1 (no) |
YU (1) | YU101692A (no) |
ZA (1) | ZA928836B (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19645974C1 (de) * | 1996-11-07 | 1998-08-13 | Andreas Johannes Kesel | (Z)-5-[[3-Hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinyl]methylen]-2-thioxo-4- thiazolidinon, Verfahren zu dessen Herstellung und Verwendung |
DE69822514T2 (de) * | 1997-12-31 | 2005-03-24 | The University Of Kansas, Lawrence | Wasserlösliche pro-pharmaka von arzneistoffen, die ein tertiäres amin enthalten, und verfahren zu ihrer herstellung |
US7893271B2 (en) | 2005-07-28 | 2011-02-22 | Intervet International B.V. | Benzimidazole carbamates and (thio) carbamates, and the synthesis and use thereof |
TWI385169B (zh) | 2005-10-31 | 2013-02-11 | Eisai R&D Man Co Ltd | 經雜環取代之吡啶衍生物及含有彼之抗真菌劑 |
CA2660647C (en) | 2006-06-14 | 2015-07-28 | Intervet International B.V. | A suspension comprising benzimidazole carbamate and a polysorbate |
TW200841879A (en) | 2007-04-27 | 2008-11-01 | Eisai R&D Man Co Ltd | Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
US8513287B2 (en) | 2007-12-27 | 2013-08-20 | Eisai R&D Management Co., Ltd. | Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same |
US8188119B2 (en) | 2008-10-24 | 2012-05-29 | Eisai R&D Management Co., Ltd | Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same |
MX365051B (es) | 2014-11-26 | 2019-05-09 | Univ Mexico Nac Autonoma | Nuevos compuestos hidrosolubles derivados del bencimidazol, utiles para el tratamiento de la fasciolosis. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ234564A (en) * | 1986-11-21 | 1991-04-26 | Haessle Ab | 1-substituted benzimidazoles and pharmaceutical compositions |
SE8801907D0 (sv) * | 1988-05-20 | 1988-05-20 | Haessle Ab | Novel pharmacological compounds |
PL166209B1 (pl) * | 1990-06-20 | 1995-04-28 | Astra Ab | Sposób wytwarzania nowych pochodnych benzimidazolu PL |
SE9002206D0 (sv) * | 1990-06-20 | 1990-06-20 | Haessle Ab | New compounds |
-
1991
- 1991-12-19 SE SE9103776A patent/SE9103776D0/xx unknown
-
1992
- 1992-10-06 IS IS4079A patent/IS4079A/is unknown
- 1992-11-11 TW TW081109053A patent/TW224100B/zh active
- 1992-11-16 ZA ZA928836A patent/ZA928836B/xx unknown
- 1992-11-25 YU YU101692A patent/YU101692A/sh unknown
- 1992-12-07 HR HR921400A patent/HRP921400A2/hr not_active Application Discontinuation
- 1992-12-08 SK SK735-94A patent/SK73594A3/sk unknown
- 1992-12-08 CZ CZ941467A patent/CZ146794A3/cs unknown
- 1992-12-08 KR KR1019940702131A patent/KR940703840A/ko not_active Application Discontinuation
- 1992-12-08 AU AU31752/93A patent/AU665043B2/en not_active Ceased
- 1992-12-08 WO PCT/SE1992/000844 patent/WO1993012124A1/en not_active Application Discontinuation
- 1992-12-08 HU HU9401840A patent/HUT68270A/hu unknown
- 1992-12-08 EP EP93900477A patent/EP0628049A1/en not_active Withdrawn
- 1992-12-08 NZ NZ246220A patent/NZ246220A/en unknown
- 1992-12-08 IL IL104025A patent/IL104025A0/xx unknown
- 1992-12-08 CA CA002124689A patent/CA2124689A1/en not_active Abandoned
- 1992-12-08 JP JP5510832A patent/JPH07502503A/ja active Pending
- 1992-12-14 AP APAP/P/1992/000463A patent/AP397A/en active
- 1992-12-15 MX MX9207269A patent/MX9207269A/es unknown
- 1992-12-16 MA MA23036A patent/MA22746A1/fr unknown
- 1992-12-18 TN TNTNSN92115A patent/TNSN92115A1/fr unknown
- 1992-12-18 CN CN92114364A patent/CN1031827C/zh not_active Expired - Fee Related
- 1992-12-18 IS IS3960A patent/IS3960A/is unknown
- 1992-12-18 SI SI19929200402A patent/SI9200402A/sl unknown
-
1994
- 1994-06-14 NO NO942230A patent/NO942230D0/no unknown
- 1994-06-17 FI FI942912A patent/FI942912A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2124689A1 (en) | 1993-06-24 |
ZA928836B (en) | 1993-07-05 |
AP9200463A0 (en) | 1993-01-31 |
SK73594A3 (en) | 1995-02-08 |
JPH07502503A (ja) | 1995-03-16 |
CN1031827C (zh) | 1996-05-22 |
AP397A (en) | 1995-08-14 |
SI9200402A (en) | 1993-06-30 |
IS3960A (is) | 1993-06-20 |
HUT68270A (en) | 1995-06-28 |
SE9103776D0 (sv) | 1991-12-19 |
AU3175293A (en) | 1993-07-19 |
FI942912A (fi) | 1994-06-17 |
MA22746A1 (fr) | 1993-07-01 |
HRP921400A2 (en) | 1994-08-31 |
FI942912A0 (fi) | 1994-06-17 |
TW224100B (no) | 1994-05-21 |
HU9401840D0 (en) | 1994-09-28 |
NO942230L (no) | 1994-06-14 |
KR940703840A (ko) | 1994-12-12 |
EP0628049A1 (en) | 1994-12-14 |
AU665043B2 (en) | 1995-12-14 |
CN1073446A (zh) | 1993-06-23 |
YU101692A (sh) | 1995-10-03 |
WO1993012124A1 (en) | 1993-06-24 |
CZ146794A3 (en) | 1996-02-14 |
NO942230D0 (no) | 1994-06-14 |
IS4079A (is) | 1993-06-20 |
NZ246220A (en) | 1996-02-27 |
MX9207269A (es) | 1993-06-01 |
IL104025A0 (en) | 1993-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU94038043A (ru) | Применение замещенных производных аденина для лечения множественного склероза | |
FR2442054A1 (fr) | Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant | |
UY23665A1 (es) | Procedimiento para la preparacion de compuesto farmaceutico | |
ATE62414T1 (de) | Mittel zur behandlung von herzerkrankungen. | |
HUP9902105A2 (hu) | Angiosztatikus dipeptideket tartalmazó gyógyászati készítmények és ezek alkalmazása | |
RU95109905A (ru) | Композиции в жидком, полутвердом, твердом, гелеобразном или пастообразном виде и способ лечения заболеваний полости рта | |
FR2512670B1 (fr) | Capsules contenant le principe actif d'un allergene et procede pour leur preparation | |
LV12766A (lv) | Composition of l-dopa esters | |
MX9605940A (es) | Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
ID24901A (id) | Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh | |
DE69132688D1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
ATE180971T1 (de) | Verwendung von fettsäureester als bioklebstoffe | |
FI19991893A (fi) | Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö | |
RU94026283A (ru) | Фармацевтическое соединение | |
ES8609325A1 (es) | Un procedimiento para preparar derivados de guanina | |
ATE268605T1 (de) | Pharmazeutische akzeptabel dnase zusammensetzung | |
TNSN92115A1 (fr) | Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisation | |
DE3879873D1 (de) | Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
RU95101385A (ru) | Продукты, содержащие g-csf и tnf связующие протеина | |
HU911184D0 (en) | Process for the production of medical preparations containing n-alkylized 1,4-dihydropirine-carbonic acid esthers and process for the production of such esthers | |
FR2713640B1 (fr) | Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations. | |
KR950031063A (ko) | 프라바스타틴을 이용하여 관상 동맥 아테롬성 동맥경화증의 진행 속도를 감소시키는 방법 | |
MD545G2 (ro) | Preparat medicamentos | |
HUP9801759A2 (hu) | Neurodegeneratív betegségek kezelésére alkalmas benzamidok | |
DE59108104D1 (de) | Arzneimittel enthaltend cd14 |